There are now many health devices that can be implanted into consumers’ bodies to help with the monitoring their health condition. These devices can communicate health data back to data storage devices where clinicians can review and act accordingly to help maintain consumers’ health. Such advances have raised questions about privacy and consent for the […]
The medicines Rituximab-pvvr and abatacept have both been shown to protect insulin-producing beta cells from immune attack, allowing people with newly diagnosed type 1 diabetes (T1D) to continue producing their own insulin for longer. This trial will look at whether combining these two medicines is better at protecting beta cells from immune attack than rituximab-pvvr […]
Antithymocyte globulin (ATG) is commonly used to prevent transplant rejection. Early research showed that ATG improved blood glucose management and preserved pancreas function in people with recently diagnosed type 1 diabetes (T1D). The STOP-T1D trial will test if ATG can delay or prevent people moving from the from pre-symptomatic stage (Stage 2) to clinically diagnosed […]
Family members of people diagnosed with type 1 diabetes (T1D) are at an increased risk of developing the condition themselves. Type1Screen is a free, JDRF-funded program available to any family members of a person diagnosed with T1D. Testing through Type1Screen can identify the early stages of T1D. Detecting T1D early, before symptoms develop, combined with […]
This clinical trial is investigating whether fenofibrate, a drug used to lower cholesterol, can slow or reverse eye damage in adults with type 1 diabetes. Fenofibrate has been shown to slow eye damage in type 2 diabetes, and researchers are now investigating whether the same effect will be seen in T1D. This study has been […]